The current research & development by business enterprise, pharmaceutical industry in current ppp $ of Iceland is 0.12 million, this is a decrease of 0.04 million (-27.5%) compared to 2021.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Iceland
No matching regions
Similar regions to Iceland
Business R&D pharmaceutical in current PPP $
More indicators for Iceland
Government R&D in security as % of government support
0%
0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
61,479.53M
+8,624.32M
(2022)
R&D financed by rest of the world in local currency
178,428.87M
-17,726.91M
(2022)
Government R&D financed by rest of the world in local currency
2,060.04M
+1,392.46M
(2022)
Business R&D financed by rest of the world in local currency
154,963.49M
-25,404.12M
(2022)
Non-profit R&D growth rate
-3.2%
-2.63%
(2009)
Iceland Business R&D pharmaceutical in current PPP $ between 2013 and 2022
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2022 | 0.12M | -0.04M |
| 2021 | 0.16M | -0.24M |
| 2020 | 0.40M | +0.06M |
| 2019 | 0.34M | -1.08M |
| 2018 | 1.42M | +0.33M |
| 2017 | 1.08M | -0.31M |
| 2016 | 1.39M | +0.40M |
| 2015 | 0.99M | +0.75M |
| 2014 | 0.24M | -0.11M |
| 2013 | 0.35M |